Tirzepatide is a synthetic peptide that acts as a dual agonist at both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Commonly utilized in preclinical and clinical research settings for the study of metabolic pathways, insulin sensitivity, adipose tissue regulation, and energy homeostasis.

Research applications include investigation of type 2 diabetes mechanisms, metabolic dysfunction, lipid metabolism, and the interplay between incretin hormones and pancreatic beta-cell function. Studies have shown Tirzepatide to exhibit dose-dependent effects on glucose regulation and body composition in research models.

Each vial contains 5mg of lyophilized Tirzepatide peptide. Reconstitute with bacteriostatic water prior to use in research applications.

Disclaimer: This product is intended for in vitro research and laboratory use only. It is not intended for human or veterinary use, consumption, or injection. Not approved by the FDA. Not intended to diagnose, treat, cure, or prevent any disease or medical condition. For use by qualified researchers only.